Avaxiga 5 mg and 10 mg FC tablets
PDF Leaflet Revision Date: 01/10/2024
Clinical Summary
Quick overview from the medicine insert
Indication
Type 2 diabetes mellitus in adults.
Dosage (summary)
10 mg once daily for monotherapy or add-on therapy.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Insulin and insulin secretagogues may increase hypoglycaemia risk.
- Diuretics may increase risk of dehydration.
Contraindications
- Type 1 diabetes
- Moderate to severe renal impairment (GFR < 45 mL/min/1.73 mu00b2)
- Hypersensitivity to dapagliflozin
- Pregnancy and breastfeeding
Common side effects
- Genital infections
- Urinary tract infections
- Hypoglycaemia (with insulin or SU)
Counselling Points
- Monitor for signs of ketoacidosis.
- Stay hydrated and report any unusual symptoms.
- Avoid use in pregnancy and breastfeeding.
Serious warnings
- Risk of metabolic acidosis and ketoacidosis.
- Monitor renal function regularly.
Important Disclaimer
The Avaxiga 5 mg and 10 mg FC tablets professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
